Company Insider Tape

Oramed Pharmaceuticals Inc. insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol ORMP Latest filing 2 Jul 2026

Company Read

Net disposal

ORMP has 4 stored insider filings. Acquisitions account for 25.0% of classified filings and disposals account for 75.0%. The largest stored filing is $611.4K from HEXTER, JOSHUA.

Latest filing 2 Jul 2026most recent stored row
Largest filing $611.4Kreported transaction value
Total filings 4stored transaction rows
Acquisition value $184.5K1 acquisitions
Disposal value $942.2K3 disposals
Net value $-757.7Kacquisitions minus disposals

Filing cadence

Last 12 active months
Jul 2026 4

Acquisitions 25.0% · Disposals 75.0%

Jul 2026 $1.1M

Executive concentration

By filing count
HEXTER, JOSHUA COO & CBO · 3 filings
GABAY, AVRAHAM Chief Financial Officer · 1 filings

Market Context

ORMP weekly market snapshot

Week 31 Jul 2026
Latest close 13.50 ILAstored weekly close
1-week move +4.2%latest weekly bar
13-week move -7.7%medium-term context
Relative Strength -75.1Sharemaestro indicator
Fair value gap -51.4%price vs fair value
Trend signal 0smoothed trend state

Transaction History

Latest insider filings for ORMP

Showing 1-4 of 4
Date 2 Jul 2026
Insider HEXTER, JOSHUACOO & CBO
Side Acquisition
Shares 50000
Price 3.69
Value 184500
Security Common Stock
Date 2 Jul 2026
Insider HEXTER, JOSHUACOO & CBO
Side Disposal
Shares 50000
Price 0.00
Value 0
Security Stock option (right to buy)
Date 1 Jul 2026
Insider HEXTER, JOSHUACOO & CBO
Side Disposal
Shares 137000
Price 4.46
Value 611431
Security Common Stock
Date 1 Jul 2026
Insider GABAY, AVRAHAMChief Financial Officer
Side Disposal
Shares 73360
Price 4.51
Value 330744
Security Common Stock